Advertisement
Perioperative Anesthesia and Analgesia in Total Joint Arthroplasty Guidelines 2020| Volume 35, ISSUE 10, P2704-2708, October 2020

Nonsteroidal Anti-Inflammatory Drugs in Total Joint Arthroplasty: The Clinical Practice Guidelines of the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society

  • Yale A. Fillingham
    Correspondence
    Reprint requests: Yale A. Fillingham, MD, Department of Orthopaedic Surgery, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756.
    Affiliations
    Department of Orthopaedic Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH
    Search for articles by this author
  • Charles P. Hannon
    Affiliations
    Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL
    Search for articles by this author
  • Karl C. Roberts
    Affiliations
    Department of Orthopaedic Surgery, Michigan State University, Grand Rapids, MI
    Search for articles by this author
  • Author Footnotes
    2 Workgroup Comprised of the following individuals: Justin T. Deen MD (Department of Orthopedics and Rehabilitation, University of Florida College of Medicine, Gainesville, FL, USA), Greg A. Erens MD (Department of Orthopedic Surgery, Emory University, Atlanta, GA, USA), Jess H. Lonner MD (Rothman Institute at Thomas Jefferson University, Philadelphia, PA, USA), Aidin E. Pour MD (Department of orthopedic surgery, University of Michigan, Ann Arbor, MI, USA), Robert S. Sterling MD (Department of Orthopedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA).
    AAHKS Anesthesia & Analgesia Clinical Practice Guideline Workgroup
    Footnotes
    2 Workgroup Comprised of the following individuals: Justin T. Deen MD (Department of Orthopedics and Rehabilitation, University of Florida College of Medicine, Gainesville, FL, USA), Greg A. Erens MD (Department of Orthopedic Surgery, Emory University, Atlanta, GA, USA), Jess H. Lonner MD (Rothman Institute at Thomas Jefferson University, Philadelphia, PA, USA), Aidin E. Pour MD (Department of orthopedic surgery, University of Michigan, Ann Arbor, MI, USA), Robert S. Sterling MD (Department of Orthopedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA).
    Authors List
  • Author Footnotes
    1 Denotes co-senior authors.
    William G. Hamilton
    Footnotes
    1 Denotes co-senior authors.
    Affiliations
    Anderson Orthopedic Research Institute, Alexandria, VA
    Search for articles by this author
  • Author Footnotes
    1 Denotes co-senior authors.
    Craig J. Della Valle
    Footnotes
    1 Denotes co-senior authors.
    Affiliations
    Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL
    Search for articles by this author
  • Author Footnotes
    1 Denotes co-senior authors.
    2 Workgroup Comprised of the following individuals: Justin T. Deen MD (Department of Orthopedics and Rehabilitation, University of Florida College of Medicine, Gainesville, FL, USA), Greg A. Erens MD (Department of Orthopedic Surgery, Emory University, Atlanta, GA, USA), Jess H. Lonner MD (Rothman Institute at Thomas Jefferson University, Philadelphia, PA, USA), Aidin E. Pour MD (Department of orthopedic surgery, University of Michigan, Ann Arbor, MI, USA), Robert S. Sterling MD (Department of Orthopedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA).
      The American Association of Hip and Knee Surgeons (AAHKS), The American Academy of Orthopaedic Surgeons (AAOS), The Hip Society, The Knee Society and The American Society of Regional Anesthesia and Pain Medicine have worked together to develop evidence-based guidelines on the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in primary total joint arthroplasty (TJA). The purpose of these guidelines is to improve the treatment of orthopedic surgical patients and reduce practice variation by promoting a multidisciplinary evidenced-based approach on the use of NSAIDs following primary TJA.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Arthroplasty
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American Academy of Orthopaedic Surgeons
        Clinical Practice Guideline and Systematic Review Methodology.
        ([accessed 01.04.2020])
        • Camu F.
        • Beecher T.
        • Recker D.P.
        • Verburg K.M.
        Valdecoxib, a COX-2-specific inhibitor, is an efficacious, opioid-sparing analgesic in patients undergoing hip arthroplasty.
        Am J Ther. 2002; 9: 43-51
        • Chen J.
        • Zhu W.
        • Zhang Z.
        • Zhu L.
        • Zhang W.
        • Du Y.
        Efficacy of celecoxib for acute pain management following total hip arthroplasty in elderly patients: a prospective, randomized, placebo-control trial.
        Exp Ther Med. 2015; 10: 737-742https://doi.org/10.3892/etm.2015.2512
        • Dahl V.
        • Raeder J.C.
        • Drosdal S.
        • Wathne O.
        • Brynildsrud J.
        Prophylactic oral ibuprofen or ibuprofen-codeine versus placebo for postoperative pain after primary hip arthroplasty.
        Acta Anaesthesiol Scand. 1995; 39: 323-326https://doi.org/10.1111/j.1399-6576.1995.tb04070.x
        • Gong L.
        • Dong J.Y.
        • Li Z.R.
        Effects of combined application of muscle relaxants and celecoxib administration after total knee arthroplasty (TKA) on early recovery: a randomized, double-blind, controlled study.
        J Arthroplasty. 2013; 28: 1301-1305https://doi.org/10.1016/j.arth.2012.10.002
        • Handel M.
        • Phillips O.
        • Anders S.
        • Kock F.X.
        • Sell S.
        Dose-dependent efficacy of diclofenac-cholestyramine on pain and periarticular ossifications after total hip arthroplasty: a double-blind, prospective, randomised trial.
        Arch Orthop Trauma Surg. 2004; 124: 483-485https://doi.org/10.1007/s00402-004-0699-9
        • Huang Y.M.
        • Wang C.M.
        • Wang C.T.
        • Lin W.P.
        • Horng L.C.
        • Jiang C.C.
        Perioperative celecoxib administration for pain management after total knee arthroplasty - a randomized, controlled study.
        BMC Musculoskelet Disord. 2008; 9: 77https://doi.org/10.1186/1471-2474-9-77
        • Ittichaikulthol W.
        • Prachanpanich N.
        • Kositchaiwat C.
        • Intapan T.
        The post-operative analgesic efficacy of celecoxib compared with placebo and parecoxib after total hip or knee arthroplasty.
        J Med Assoc Thai. 2010; 93: 937-942
        • Jianda X.
        • Yuxing Q.
        • Yi G.
        • Hong Z.
        • Libo P.
        • Jianning Z.
        Impact of Preemptive analgesia on inflammatory responses and Rehabilitation after primary total knee arthroplasty: a controlled clinical study.
        Sci Rep. 2016; 6: 30354https://doi.org/10.1038/srep30354
        • McQuay H.J.
        • Moore R.A.
        • Berta A.
        • Gainutdinovs O.
        • Fulesdi B.
        • Porvaneckas N.
        • et al.
        Randomized clinical trial of dexketoprofen/tramadol 25 mg/75 mg in moderate-to-severe pain after total hip arthroplasty.
        Br J Anaesth. 2016; 116: 269-276https://doi.org/10.1093/bja/aev457
        • Meunier A.
        • Lisander B.
        • Good L.
        Effects of celecoxib on blood loss, pain, and recovery of function after total knee replacement: a randomized placebo-controlled trial.
        Acta Orthop. 2007; 78: 661-667https://doi.org/10.1080/17453670710014365
        • Munteanu A.M.
        • Cionac Florescu S.
        • Anastase D.M.
        • Stoica C.I.
        Is there any analgesic benefit from preoperative vs. postoperative administration of etoricoxib in total knee arthroplasty under spinal anaesthesia?: a randomised double-blind placebo-controlled trial.
        Eur J Anaesthesiol. 2016; 33: 840-845https://doi.org/10.1097/EJA.0000000000000521
        • Rawal N.
        • Viscusi E.
        • Peloso P.M.
        • Minkowitz H.S.
        • Chen L.
        • Shah S.
        • et al.
        Evaluation of etoricoxib in patients undergoing total knee replacement surgery in a double-blind, randomized controlled trial.
        BMC Musculoskelet Disord. 2013; 14: 300https://doi.org/10.1186/1471-2474-14-300
        • Reynolds L.W.
        • Hoo R.K.
        • Brill R.J.
        • North J.
        • Recker D.P.
        • Verburg K.M.
        The COX-2 specific inhibitor, valdecoxib, is an effective, opioid-sparing analgesic in patients undergoing total knee arthroplasty.
        J Pain Symptom Manage. 2003; 25: 133-141https://doi.org/10.1016/s0885-3924(02)00637-1
        • Serpell M.G.
        • Thomson M.F.
        Comparison of piroxicam with placebo in the management of pain after total hip replacement.
        Br J Anaesth. 1989; 63: 354-356https://doi.org/10.1093/bja/63.3.354
        • Weber E.W.
        • Slappendel R.
        • Durieux M.E.
        • Dirksen R.
        • van der Heide H.
        • Spruit M.
        COX 2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam.
        Eur J Anaesthesiol. 2003; 20: 963-966https://doi.org/10.1017/s0265021503001558
        • de Miguel Rivero C.A.G.
        • Sousa M.M.
        • Lopez de Rueda F.S.
        • Gonzalez F.L.
        • Marquez A.P.
        • de Anta Barrio J.
        Comparative efficacy of oral ibuprofen-arginine, intramuscular magnesic dipyrone and placebo in patients with postoperative pain following total hip replacement.
        Clin Drug Invest. 1997; 14: 276-285
        • Florescu C.S.
        • Anastase D.M.
        • Munteanu A.M.
        • Porumbac G.
        • Mihailide N.A.
        Randomized Parallel controlled study of the efficacy and safety of Lornoxicam versus etoricoxib after total knee arthroplasty.
        Int J Anesth Res. 2016; 4: 373-376
        • Schroer W.C.
        • Diesfeld P.J.
        • LeMarr A.R.
        • Reedy M.E.
        Benefits of prolonged postoperative cyclooxygenase-2 inhibitor administration on total knee arthroplasty recovery: a double-blind, placebo-controlled study.
        J Arthroplasty. 2011; 26: 2-7https://doi.org/10.1016/j.arth.2011.04.007
        • Memtsoudis S.G.
        • Poeran J.
        • Zubizarreta N.
        • Cozowicz C.
        • Morwald E.E.
        • Mariano E.R.
        • et al.
        Association of multimodal pain management Strategies with perioperative outcomes and Resource utilization: a Population-based study.
        Anesthesiology. 2018; 128: 891-902https://doi.org/10.1097/ALN.0000000000002132
        • Alexander R.
        • El-Moalem H.E.
        • Gan T.J.
        Comparison of the morphine-sparing effects of diclofenac sodium and ketorolac tromethamine after major orthopedic surgery.
        J Clin Anesth. 2002; 14: 187-192https://doi.org/10.1016/s0952-8180(01)00382-8
        • Etches R.C.
        • Warriner C.B.
        • Badner N.
        • Buckley D.N.
        • Beattie W.S.
        • Chan V.W.
        • et al.
        Continuous intravenous administration of ketorolac reduces pain and morphine consumption after total hip or knee arthroplasty.
        Anesth Analg. 1995; 81: 1175-1180https://doi.org/10.1097/00000539-199512000-00010
        • Fletcher D.
        • Zetlaoui P.
        • Monin S.
        • Bombart M.
        • Samii K.
        Influence of timing on the analgesic effect of intravenous ketorolac after orthopedic surgery.
        Pain. 1995; 61: 291-297https://doi.org/10.1016/0304-3959(94)00184-g
        • Fragen R.J.
        • Stulberg S.D.
        • Wixson R.
        • Glisson S.
        • Librojo E.
        Effect of ketorolac tromethamine on bleeding and on requirements for analgesia after total knee arthroplasty.
        J Bone Jt Surg Am. 1995; 77: 998-1002https://doi.org/10.2106/00004623-199507000-00004
        • Kostamovaara P.A.
        • Hendolin H.
        • Kokki H.
        • Nuutinen L.S.
        Ketorolac, diclofenac and ketoprofen are equally efficacious for pain relief after total hip replacement surgery.
        Br J Anaesth. 1998; 81: 369-372https://doi.org/10.1093/bja/81.3.369
        • Rasmussen G.L.
        • Steckner K.
        • Hogue C.
        • Torri S.
        • Hubbard R.C.
        Intravenous parecoxib sodium foracute pain after orthopedic knee surgery.
        Am J Orthop. 2002; 31: 336-343
        • Zhou T.J.
        • Tang J.
        • White P.F.
        Propacetamol versus ketorolac for treatment of acute postoperative pain after total hip or knee replacement.
        Anesth Analg. 2001; 92: 1569-1575https://doi.org/10.1097/00000539-200106000-00044